FDA Inspection
AstraZeneca Pharmaceuticals LPAstraZeneca Pharmaceuticals LP – FDA Inspection, Jun 20, 2018
Record Details
This FDA Inspection record concerns AstraZeneca Pharmaceuticals LP, with an inspection on June 20, 2018, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · 500df3a2-86d2-4a61-9aca-64742d4d4bf0
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1060670
- FDA center
- Biologics
- Project area
- Vaccines and Allergenic Products
- Outcome
- Form 483 issued
Other FDA inspections of AstraZeneca Pharmaceuticals LP
8| Date | Classification | Office | Project area |
|---|---|---|---|
| June 24, 2025 | NAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
| July 22, 2022 | VAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
| May 20, 2015 | VAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
| May 22, 2013 | VAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
| May 3, 2011 | VAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
Other documents for AstraZeneca Pharmaceuticals LP
- FDA Inspection 1277181 - 2025-06-24
- FDA Inspection 1175133 - 2022-07-22
- FDA Inspection 940375 - 2015-05-20
- FDA Inspection 846805 - 2013-05-22
- FDA Inspection 747381 - 2011-05-03
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.